$CTIC Recent Headlines Insider filings one way to track

New Post Public Reply Private Reply Replies (0) Message Board

Apr 17, 2014 at 12:08 PM

$CTIC Recent Headlines

Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 4:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 7:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 8:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 7:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 6:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 10:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 5:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 11:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 2:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 5:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 5:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 4:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 9:09 a.m. June 30, 2011 - MarketWatch.com

Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape 9:21 a.m. April 10, 2014 - Zacks.com
Insider Trading Alert - CTIC, KR And IBKR Traded By Insiders 10:45 a.m. March 31, 2014 - TheStreet.com
Zacks Rank #1 Additions for Friday - Tale of the Tape 9:30 a.m. March 28, 2014 - Zacks.com
First Week Of CTIC May 17th Options Trading 12:54 p.m. March 26, 2014 - TheStreet.com
Cell Therapeutics: 5 Different Insiders Have Sold Shares This Month 10:39 a.m. March 24, 2014 - Seeking Alpha
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ... 10:12 a.m. March 24, 2014 - GuruFocus.com
Geron: FDA Suspends Key Myelofibrosis Drug Due to Liver Safety Concerns 9:57 a.m. March 12, 2014 - TheStreet.com
Insider Trading Alert - CTIC, TCBI And FCS Traded By Insiders 1:16 p.m. March 10, 2014 - TheStreet.com
Is It Too Late to Buy the Rally in Small Caps? 12:00 a.m. March 7, 2014 - InvestorPlace.com
Cell Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 9:21 p.m. March 4, 2014 - Seeking Alpha
10-K: CELL THERAPEUTICS INC 5:32 p.m. March 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics Q4 revenue soars due to Baxter license payment 4:49 p.m. March 4, 2014 - Seeking Alpha
Cell Therapeutics' Pixuvri gets final NICE recommendation 9:47 a.m. Feb. 27, 2014 - Seeking Alpha
Interesting CTIC Put And Call Options For April 19th 11:01 a.m. Feb. 26, 2014 - TheStreet.com
NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule 7:33 a.m. Feb. 26, 2014 - TheStreet.com
TetraLogic Pharmaceuticsls And The Chatter About A Cure For Cancer 5:18 p.m. Jan. 31, 2014 - Seeking Alpha
Biotech Stock Mailbag: Cell Therapeutics and the Ariad Hostile React-o-Meter Meltdown 6:00 a.m. Jan. 31, 2014 - TheStreet.com
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Jan. 28, 2014 - Seeking Alpha
First Week Of CTIC January 2016 Options Trading 1:18 p.m. Jan. 22, 2014 - TheStreet.com
Cell Therapeutics (CTIC) Highlighted As Today's Perilous Reversal Stock 9:46 a.m. Jan. 22, 2014 - TheStreet.com

Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America 8:55 a.m. March 25, 2014 - PR Newswire - PRF
Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on Cell Therapeutics, Intrexon, Chimerix, Receptos, and Revance Therapeutics 8:00 a.m. March 18, 2014 - PR Newswire - PRF
Investor-Edge.com Most Active Equities Watch List: Cell Therapeutics, Yandex, Himax Technologies, and CytRx 8:54 a.m. March 14, 2014 - PR Newswire - PRF
Cell Therapeutics to Present at the 26th Annual ROTH Conference 2:30 a.m. March 5, 2014 - PR Newswire - PRF
Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results 5:00 p.m. March 4, 2014 - PR Newswire - PRF
CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts 2:30 a.m. March 3, 2014 - PR Newswire - PRF
NICE Publishes Final Guidance on PIXUVRI® (pixantrone) 2:30 a.m. Feb. 27, 2014 - PR Newswire - PRF
Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014 2:30 a.m. Feb. 25, 2014 - PR Newswire - PRF
Hercules Offshore Losses Decrease from $121 million to $27 million 10:17 a.m. Feb. 24, 2014 - ACCESSWIRE
Glu Mobile and Siri XM Stock Volume Soars on Fourth-Quarter Results: Glu Mobile Inc.'s (NASDAQ: GLUU), Sirius XM Holdings Inc. (NASDAQ: SIRI), Zynga Inc. (NASDAQ:ZNGA, Cell Therapeutics Inc. (NASDAQ:CTIC) 11:12 a.m. Feb. 11, 2014 - ACCESSWIRE
Cell Therapeutics Appoints Karen Ignagni to Board of Directors 2:30 a.m. Feb. 3, 2014 - PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia 2:30 a.m. Jan. 30, 2014 - PR Newswire - PRF
Cell Therapeutics Announces GOG Completes Patient Enrollment in GOG-0212 Phase 3 Clinical Trial of Paclitaxel Poliglumex (Opaxio™) as Maintenance Therapy in Ovarian Cancer 2:30 a.m. Jan. 28, 2014 - PR Newswire - PRF
Most Active Stocks Range from Online Game Maker to Biopharmaceuticals: Zynga Inc. (NASDAQ:ZNGA), Dynavax Technologies Corp. (NASDAQ: DVAX), Cell Therapeutics Inc. (NASDAQ:CTIC) 8:23 a.m. Jan. 20, 2014 - ACCESSWIRE
Morning Buzzers: Cell Therapeutics Inc, Stratasys, Galena Biopharma, Cliffs Natural Resources 11:52 a.m. Jan. 14, 2014 - ACCESSWIRE
Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress 2:30 a.m. Jan. 14, 2014 - PR Newswire - PRF
Cell Therapeutics Reaches Agreement to Reacquire Rights to Two Anti-Cancer Compounds 2:30 a.m. Jan. 13, 2014 - PR Newswire - PRF
Study Updates, Notices, Quarterly Reports, and Revenue Guidance Updates - Research Report on NPS Pharmaceuticals, Oramed, PAREXEL, PhotoMedex, and Cell Therapeutics 9:00 a.m. Jan. 7, 2014 - PR Newswire
PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from NICE 2:30 a.m. Jan. 6, 2014 - PR Newswire
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 9:00 a.m. Jan. 2, 2014 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beverly Hills MD's Dermal Cream Wins Key Beauty Award

A Surprise Win in the Beauty World Who doesn't love an underdog story, right? Beverly Hills MD has slid into the limelight with their Dermal Repair Complex snagging the award for 'Beauty Product of the Year.' Talk about sending shockwaves through the beauty industry! Now, these guys might not be a household name yet, but you better believe they've got everyone's attention...

Curaleaf Expands in Florida Amid Rising Cannabis Demand

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...

AI Platform Suno Sued for Exploiting Artists' Identities

AI and the Music Business: A Legal Storm Brews Well, it looks like the music world’s hitting a rough patch with AI in the crosshairs. We've got Korein Tillery, a heavyweight in the legal arena, throwing down the gauntlet against Suno, an AI music-generation platform. Folks, welcome to the battleground where art meets tech and identity theft takes a whole new meaning....

Rackspace Lawsuit Deadline: Investors Must Take Action

Rackspace's Legal Predicament: Time for Action Alright folks, if you're holding shares of Rackspace Technology (NASDAQ:RXT), it’s time to sit up and pay attention. This is about more than bad PR or a temporary hiccup in the stock price—this is serious business. We’ve got until September 28, 2026, to decide if we’re in or out on this class action lawsuit train....

Clinical Trials Services Market Set for Big Growth

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Art and Science Blend in Dr. De La Cruz's Approach

Redefining Aesthetic Surgery: An Artistic Approach The world of plastic surgery is often seen through the lens of beauty and symmetry, but for Dr. Emmanuel De La Cruz, it's like staring into a whole different universe. This Houston-based plastic surgeon isn't just removing fat—he's reshaping the human canvas with the eye of a sculptor. Beyond the Standard Cut and Snip...

IVD Study Success: Hybrid Monitoring Boosts Oversight

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

CAPR Faces Lawsuit and FDA Delay: Investor Alert

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Orbis Celebrates 20 Years of Eye Care in Macau

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Faruqi & Faruqi Urge Wix Investors to Act Now

Ticking Clock for Wix Investors' Legal Moves The buzz in the stock market is louder than a bull on Wall Street, especially if you're tangled up with Wix.com Ltd. (NASDAQ: WIX). We've got Faruqi & Faruqi, LLP laying down serious advice: move fast or maybe lose your spot in line. The deadline to noodle over your position as a lead plaintiff in their federal securities class...